Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Connetics expands dermatology pipeline

Dec. 30, 1999

Janssen group presents preparation, activity and use of new PDE4/TNF-alpha inhibitors

Dec. 28, 1999

Biomatrix receives go-ahead to test product for preventing lumbar postsurgical adhesions

Dec. 28, 1999

Organogenesis seeks FDA approval of Apligraf for diabetic foot ulcers

Dec. 23, 1999

Biomatrix files 510K submission for sinus surgery adhesion prevention device

Dec. 23, 1999

Novartis discloses several new compounds for proliferative, inflammatory conditions

Dec. 22, 1999

Soltec enters strategic alliance with Mipharm

Dec. 22, 1999

Anti-CD11a enters phase III for psoriasis

Dec. 21, 1999

Cellegy to conduct second phase III trial with Anogesic

Dec. 17, 1999

Pfizer investigates antipruritic activity of 4-phenylpiperidines

Dec. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...